Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History

Recruiting Phase 1 Interventional Study
Abortion, Habitual Infertility Unexplained Embryo Implantation Pre-Eclampsia
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
22 – 40
Sex
Female
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
14 (estimated)
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of this study is preliminary exploration of the effectiveness and duration of autologous decidual-like NK cells therapy in improving uterine NK cells dysfunction.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * abnormal uterine NK cell function; * have one of the following medical history: unexplained recurrent spontaneous abortions (≥2 spontaneous abortions, including biochemical pregnancy), repeated implantation failure (failure of implantation of good-quality embryos in at least t…
Contacts

Yali Hu

86-025-83106666

glyyhuyali@163.com

CONTACT

Hui Zhu

86-025-83106666

zhuhui1231@126.com

CONTACT